Clinical Trial Update: Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma [NA]

View source ↗

Summary

A clinical trial comparing injectable platelet-rich fibrin to intradermal tranexamic acid for melasma is currently recruiting, sponsored by Kasr El Aini Hospita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Injectable Platelet Rich Fibrin (platelet-rich fibrin)
• Tranexamic acid (intradermal) (tranexamic acid)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Melasma, Facial Melasma | NA | Status: RECRUITING